Table 2.
CHARACTERISTIC | NO. OF PATIENTS, (%) | UNIVARIATE ANALYSIS | MULTIVARIATE LOGISTIC REGRESSION ANALYSIS P | ||||
---|---|---|---|---|---|---|---|
ALIVE | DEAD | P | RR (95% CI) | ||||
Age | |||||||
<50 years | 71 | 95.9% | 3 | 4.1% | |||
>50 years | 104 | 86.0% | 17 | 14.0% | <.01 | 4.1 (1.2–13.4) | .95 |
AJCC stage | |||||||
I and II | 113 | 95.8% | 5 | 4.2% | |||
III and IV | 55 | 75.3% | 18 | 24.7% | <.001 | 5.8 (2.25–414.9) | .59 |
Histologic grade | |||||||
1 and 2 | 93 | 92.1% | 8 | 7.9% | |||
3 | 53 | 85.5% | 9 | 14.5% | .18 | 1.8 (0.74–4.5) | NA |
Lymphovascular invasion | |||||||
Absent | 34 | 100% | 0 | 0% | |||
Present | 52 | 78.8% | 14 | 21.2% | .015 | NA | .94 |
Distant recurrence | |||||||
No | 172 | 94.5% | 10 | 5.5% | |||
Yes | 2 | 18.2% | 9 | 81.8% | <.001 | 14.9 (7.7–28.9) | .01 |
Local recurrence | |||||||
No | 173 | 90.1% | 19 | 9.9% | |||
Yes | 2 | 28.6% | 5 | 71.4% | <.001 | 7.2 (3.8–13.6) | .06 |
Immunohistochemical subtype | |||||||
HR+HER2−, HR+HER2+, and HR−HER2+ | 148 | 91.9% | 13 | 8.1% | |||
HR−HER2− | 25 | 73.5% | 9 | 26.5% | <.001 | 2.7 (1.2–5.8) | .93 |
Abbreviations: RR, relative risk; CI, confidence interval.